Oncology Business Management

Alessandra Ferrajoli, MD, discusses the recent approval of ibrutinib for patients with chronic lymphocytic leukemia (CLL) who have received at least one previous therapy.

"Are you making progress?" is one of the questions you are most frequently being asked as an oncologist-even in social settings.

To reduce the costs of cancer, community oncologists increase the use of evidence-based treatments, standardize care with pathways, transition away from fee-for-service, and change communication with patients about reasonable end-of-life care.

A study published in the New England Journal of Medicine sparked controversy and criticism when it claimed that many men received unnecessary radiation therapy for their prostate cancer due to self-referral.

Oncology practices looking to update their EHR to be ICD-10 compliant are facing an even greater cost than originally estimated.

The mantra in oncology over the last several years has revolved around how practices should deal with the myriad of challenges they face: new guidelines and regulations, lower reimbursement and a shift toward value-based patient care.

Regional Cancer Care Associates will collaborate with OncLive to develop informative resources for oncology professionals that advance patient care.

Biopharmaceutical companies that administer patient assistance programs (PAPs) well in terms of service and support parameters seem to benefit from a halo effect among their oncologist customers, according to "PAP Utilization in Cancer Care," a Cogent Reports survey from Market Strategies International, a market research company.

The FDA has expanded the approval of ibrutinib to include the treatment of patients with chronic lymphocytic leukemia who have received at least one previous therapy.

Providers who are eligible to participate in the Centers for Medicare & Medicaid Services (CMS) electronic health record (EHR) incentive program have a one month reprieve to show that their practices are using the technology in a meaningfully useful way.

The FDA has granted a priority review designation to the intravenous pan-HDAC inhibitor belinostat (Beleodaq) as a treatment for patients with relapsed or refractory peripheral T-cell lymphoma

Lawmakers have moved to reform Medicare's troublesome physician payment formula with an update that uses a single conversion factor to determine the physician fee schedule.

Genmab, the publicly traded, international biotechnology company, has an oncology pipeline that focuses on two classes of drugs: naked antibodies and antibody drug conjugates

A news story from Bloomberg Business News suggests that insurers who are participating in government-run health insurance exchanges will be required to increase "essential community providers" in their local geographic area by 30% by 2015.

Although new physician compensation models promote pay-for-value, episodic bundles, and risk-adjusted bundles, physicians in non-solo practices are compensated using four methods: base salary, compensation based on personal productivity, compensation based on practice financial performance, and bonus based on factors other than personal productivity and practice financial performance.

Eltrombopag has received a Breakthrough Therapy designation from the FDA for the treatment of cytopenias in patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy.

A survey about physician practice readiness for the upcoming ICD-10 deadline suggests that half will only start preparing in May 2014 for the transition.

Creating an enhanced, common health information exchange (HIE) pipeline where clinicians, payers, and patients share structured information from multiple electronic medical record/electronic record platforms would effectively manage costs and enhance patient care in oncology, according to a recent paper published in the Journal of Oncology Practice.

Accessing and processing data from the Centers for Medicare & Medicaid (CMS) is the leading operational challenge faced by accountable care organizations (ACOs), according to a large-scale survey conducted by the National Association of ACOs.

While hospitals and cancer centers are taking cues from the hospitality industry, office practices are learning that improving the patient flow aids in running an efficient office.

While hospitals and cancer centers are taking cues from the hospitality industry-think hoteliers like Marriott, Hyatt, and even Ritz-Carlton-office practices are learning that improving the patient flow aids in running an efficient office. That is translating into increased profitability.

Organization into large group practices will be a key way for urologists to successfully navigate a healthcare system that continues to be fraught with an enormous amount of change, a keynote speaker said during LUGPA's annual meeting in Chicago in November.

A new medication tracking system to counter drug diversion and counterfeiting might have some oncologists feeling a little safer about the chemotherapy they prescribe for their patients.

Dartmouth University researchers started investigating the phenomenon called the Cherenkov effect in 2011

The classic saying Have a Happy and Healthy New Year takes a particularly important meaning this year, as Jan 1, 2014, is now a landmark date in the history of US healthcare with the implementation of the Affordable Care Act (ACA), also referred to as Obamacare

OncLive will work with Georgia's only NCI-designated cancer center to support its efforts to conduct innovative, multidisciplinary research and translate that knowledge into excellent patient care.

Deepak A. Kapoor, MD, former president of the Large Urology Group Practice Association (LUGPA), discusses the successes of and challenges facing LUGPA.

When a patient receives the diagnosis of cancer, regardless of stage or severity of the disease, one of the many questions asked is how to pay for the treatment.